As of Jul 26
| -1.29 / -12.71%|
The 1 analysts offering 12-month price forecasts for Madrigal Pharmaceuticals Inc have a median target of 22.75, with a high estimate of 22.75 and a low estimate of 22.75. The median estimate represents a +156.77% increase from the last price of 8.86.
The current consensus among 1 polled investment analysts is to Hold stock in Madrigal Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.